BSE filing, BSE: 543518. Summary written from the filing by ALFA Finder's alert engine.
Eighty Jewellers Ltd: key numbers
- Share price
- ₹44.00
- Market cap
- ₹44.88 Cr
- Revenue (annual)
- ₹128.3 Cr
- Net profit (annual)
- ₹9.74 Cr
- P/E (TTM)
- 4.6×Sector 49.5×
- Promoter holding
- 73.53%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eighty Jewellers Ltd
All →Eighty Jewellers Management Change
Eighty Jewellers Limited has announced the re-appointment of four directors, including Executive and Independent Directors, for a term of 60 months effective December 6, 2026.
Eighty Jewellers Annual General Meeting
Eighty Jewellers Ltd held its 16th Annual General Meeting on September 29, 2026. The meeting covered adoption of financial statements and re-appointment of directors.
Eighty Jewellers Annual Report
Eighty Jewellers Ltd has submitted its Annual Report for the FY 2025-26, including the notice for the 16th AGM to be held on September 29, 2026.
Eighty Jewellers Annual General Meeting
Eighty Jewellers Ltd has scheduled its 16th Annual General Meeting on 29th September 2026. The meeting will address financial statements and director re-appointments.
Eighty Jewellers Management Change
Eighty Jewellers Ltd has appointed CS Sureha Jain as the Company Secretary and Compliance Officer, effective September 1, 2026. She serves as Key Managerial Personnel.
Eighty Jewellers Board Meeting Outcome
Eighty Jewellers Ltd announced board meeting outcomes, including the appointment of a company secretary, director re-appointments, and scheduling the 16th AGM for September 29, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.